World's first man to get Covid-19 vaccine dies of unrelated illness in UK

An 81-year-old pensioner in the UK who made history when he became the first man in the world to have the COVID-19 vaccination has died of an unrelated illness, the British media reported on Tuesday.

vaccine, vaccination, coronavirus, covid, medical, health, drugs
Press Trust of India London
2 min read Last Updated : May 26 2021 | 1:59 AM IST

An 81-year-old pensioner in the UK who made history when he became the first man in the world to have the COVID-19 vaccination has died of an unrelated illness, the British media reported on Tuesday.

William Shakespeare hit global headlines on December 8 last year when he became the first man to have the jab to fight against the coronavirus at the University Hospital Coventry and Warwickshire.

Shakespeare received his first Pfizer-BioNTech vaccine at the same hospital shortly after 91-year-old Margaret Keenan, who became the world's first person to get the jab.

Coventry councillor Jayne Innes, a friend of Shakespeare, said he had died on Thursday (May 20) and added the "best tribute to Bill is to have the jab".

Bill, as he was fondly known, passed away after a period of illness at the same hospital where he famously received his vaccine, CoventryLive reported.

Shakespeare had worked at Rolls Royce and was a parish councillor.

Shakespeare had served his local community in Allesley for more than three decades and was an inpatient on the hospital's frailty ward at the time of his first jab, said it had been "wonderful".

Shakespeare leaves his wife Joy, their two adult sons and grandchildren, the BBC reported.

West Midlands Labour group said on Twitter: "Bill made global headlines as [the first] man to have Covid vaccine.

"His decades of service to the party were recently recognised by Labour Party leader Keir Starmer.

"Our thoughts are with Joy and Bill's family and friends.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Coronavirus VaccineVaccinationUK

First Published: May 26 2021 | 1:57 AM IST

Next Story